Global Antibody Drug Conjugates Market to 2030: Rising Incidences of Cancer Worldwide Bolsters Growth


Dublin, June 01, 2023 (GLOBE NEWSWIRE) -- The "Global Antibody Drug Conjugates Market Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.

The Global Antibody Drug Conjugates Market was valued at USD 6.75 billion in 2022 and is expected to expand to USD 21.85 billion by 2030, at a CAGR of 12.70% during the forecast period 2023-2030.

Companies Mentioned

  • Seagen Inc.
  • Takeda Pharmaceutical Company Limited
  • AstraZeneca
  • F. Hoffmann-La Roche Ltd.
  • Pfizer Inc.
  • Gilead Sciences Inc.
  • Daiichi Sankyo Company Limited
  • GlaxoSmithKline plc
  • Astellas Pharma Inc.
  • ADC Therapeutics SA

Antibody-drug conjugates or ADCs are a class of biopharmaceutical drugs that are designed as targeted therapy for the treatment of cancer. Unlike chemotherapy, antibody-drug conjugates are intended to aim and kill tumor cells while sparing healthy cells.

Market Drivers

The global antibody drug conjugates market is mainly driven by rising incidences of cancer worldwide. According to the Cancer Research of the UK, the number of new cancer cases globally is expected to reach approx. 27.9 million by 2040. Main factors such as smoking, obesity, alcohol, and unhealthy diet are the major reasons for increasing cancer cases worldwide.

Furthermore, funding & investment in this field by the key players for the development of new antibody-drug conjugates intended for the treatment of cancer is expected to drive the global antibody-drug conjugates market growth. Also, advanced technological advancements are driving the growth of the market.

Market Restraints

The high cost of treatment & procedures, various stringent government regulations & FDA approvals, and lack of funds are expected to restrain the global antibody drug conjugates market growth over the forecast period of 2030.

Market Segmentation

By Product Type

  • Adcetris
  • Kadcyla
  • Others

By Application

  • Blood Cancer
  • Breast Cancer
  • Urothelial/Bladder Cancer

By Technology

  • Cleavable
  • Non-cleavable

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

For more information about this report visit https://www.researchandmarkets.com/r/e9pokg

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

 

Contact Data